Fig. 4: The combination of TNM stage and the constructed model helps to identify patient subgroups who may particularly benefit from postoperative chemotherapy.

a–f Validation cohort 1; g–l validation cohort 2. ACT adjuvant chemotherapy.

a–f Validation cohort 1; g–l validation cohort 2. ACT adjuvant chemotherapy.